Sernova to amend warrants, extend expiry, and cut exercise price
Source: SeekingAlpha
2026-02-20 07:56:39 ET
More on Sernova Biotherapeutics Inc
- Seeking Alpha’s Quant Rating on Sernova Biotherapeutics Inc
- Historical earnings data for Sernova Biotherapeutics Inc
- Financial information for Sernova Biotherapeutics Inc
Read the full article on Seeking Alpha
For further details see:
Sernova to amend warrants, extend expiry, and cut exercise price
Sernova Corp.
NASDAQ: SVA:CC
SVA:CC Trading
1.43% G/L:
$1.42 Last:
360,144 Volume:
$1.41 Open:
SVA:CC Latest News
March 04, 2026 07:00:00 am
Sernova Biotherapeutics Strengthens Balance Sheet with $7.1 Million in Financings Plus Net Retirement of a Cumulative $17 Million of Debt Subject to Shareholder Approval
December 16, 2025 12:00:04 pm
From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes
